Mean arterial pressure and mortality in patients with heart failure: a retrospective analysis of Zigong heart failure database.
Journal
Blood pressure monitoring
ISSN: 1473-5725
Titre abrégé: Blood Press Monit
Pays: England
ID NLM: 9606438
Informations de publication
Date de publication:
01 Dec 2023
01 Dec 2023
Historique:
medline:
2
11
2023
pubmed:
13
9
2023
entrez:
13
9
2023
Statut:
ppublish
Résumé
It is commonly observed that a higher target of mean arterial pressure (MAP) is in previous studies. This study assessed the association of MAP with short-term mortality in heart failure (HF) patients. A retrospective cohort study was conducted by using data from Hospitalized patients with heart failure: integrating electronic healthcare records and external outcome database (v1.2 ). The characteristic of patients was described by 3 groups of MAP: below 80 mmHg, 80-100 mmHg, and above 100 mmHg. Univariate and multivariate logistic regression analyses were used to assess the relevance between MAP and all-cause mortality within 28 days and 6 months. For assessing the effect of multiple variables on patient survival time, 28-day and 6-month, Kaplan-Meier survival analysis and Forest plot were performed. The overall cohort comprised 2008 patients divided by MAP into 3 groups, each group had 344 (17.1%), 938 (46.7%), and 726 (36.2%) patients. Patients in MAP < 80 mmHg group had higher mortality than MAP 80-100 mmHg and MAP ≥ 100 mmHg in 28 days(3.8% versus 1.6% versus 1.2%) and in 6 months (4.9% versus 2.5% versus 2.3%). Univariate analysis showed that MAP as a continuous variate was associated with 28-day (OR was 0.98, 95% CIs: 0.96-0.99, P = 0.011) and 6-month mortality (OR was 0.98, 95% CIs: 0.97-1, P = 0.021) in HF patients. Model 4 put into multivariate logistic regression analyses showed MAP 80-100 mmHg (OR was 0.13, 95% CIs: 0.02-0.8, P = 0.027) stably associated with 28-day and 6-month mortality after adjusted covariable. Kaplan-Meier survival curves revealed a higher survival rate in the MAP ≥ 80 mmHg group than in the MAP < 80 mmHg group. The forest plot showed the stable effect of MAP ≥ 80 mmHg compared with MAP < 80 mmHg, the interaction analysis had no statistical significance effect between the two groups of MAP and multi-variable. It is indicated that MAP was independently associated with 28-day, 6-month all-cause mortality of HF patients, and compared with MAP < 80 mmHg, MAP ≥ 80 mmHg had a lower risk of 28-day, 6-month all-cause mortality of patients with HF.
Sections du résumé
BACKGROUND
BACKGROUND
It is commonly observed that a higher target of mean arterial pressure (MAP) is in previous studies. This study assessed the association of MAP with short-term mortality in heart failure (HF) patients.
METHODS
METHODS
A retrospective cohort study was conducted by using data from Hospitalized patients with heart failure: integrating electronic healthcare records and external outcome database (v1.2 ). The characteristic of patients was described by 3 groups of MAP: below 80 mmHg, 80-100 mmHg, and above 100 mmHg. Univariate and multivariate logistic regression analyses were used to assess the relevance between MAP and all-cause mortality within 28 days and 6 months. For assessing the effect of multiple variables on patient survival time, 28-day and 6-month, Kaplan-Meier survival analysis and Forest plot were performed.
RESULTS
RESULTS
The overall cohort comprised 2008 patients divided by MAP into 3 groups, each group had 344 (17.1%), 938 (46.7%), and 726 (36.2%) patients. Patients in MAP < 80 mmHg group had higher mortality than MAP 80-100 mmHg and MAP ≥ 100 mmHg in 28 days(3.8% versus 1.6% versus 1.2%) and in 6 months (4.9% versus 2.5% versus 2.3%). Univariate analysis showed that MAP as a continuous variate was associated with 28-day (OR was 0.98, 95% CIs: 0.96-0.99, P = 0.011) and 6-month mortality (OR was 0.98, 95% CIs: 0.97-1, P = 0.021) in HF patients. Model 4 put into multivariate logistic regression analyses showed MAP 80-100 mmHg (OR was 0.13, 95% CIs: 0.02-0.8, P = 0.027) stably associated with 28-day and 6-month mortality after adjusted covariable. Kaplan-Meier survival curves revealed a higher survival rate in the MAP ≥ 80 mmHg group than in the MAP < 80 mmHg group. The forest plot showed the stable effect of MAP ≥ 80 mmHg compared with MAP < 80 mmHg, the interaction analysis had no statistical significance effect between the two groups of MAP and multi-variable.
CONCLUSION
CONCLUSIONS
It is indicated that MAP was independently associated with 28-day, 6-month all-cause mortality of HF patients, and compared with MAP < 80 mmHg, MAP ≥ 80 mmHg had a lower risk of 28-day, 6-month all-cause mortality of patients with HF.
Identifiants
pubmed: 37702595
doi: 10.1097/MBP.0000000000000674
pii: 00126097-990000000-00080
pmc: PMC10621646
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
343-350Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
N Engl J Med. 2014 Apr 24;370(17):1583-93
pubmed: 24635770
Crit Care. 2020 Aug 20;24(1):513
pubmed: 32819421
Eur J Heart Fail. 2019 Aug;21(8):998-1007
pubmed: 31134724
Am J Emerg Med. 2012 Jan;30(1):97-103
pubmed: 21159479
Front Cardiovasc Med. 2021 Jun 04;8:665117
pubmed: 34150867
Crit Care. 2005;9(6):601-6
pubmed: 16356245
Hypertension. 2016 Sep;68(3):642-53
pubmed: 27456518
Hypertension. 2022 Jan;79(1):241-250
pubmed: 34739763
Circulation. 2022 May 3;145(18):e895-e1032
pubmed: 35363499
Lancet. 2009 Nov 28;374(9704):1840-8
pubmed: 19922995
J Am Coll Cardiol. 2019 Jun 4;73(21):2756-2768
pubmed: 31146820
Eur Heart J. 2014 Feb;35(7):455-69
pubmed: 24164864
Eur Heart J. 2013 May;34(19):1404-13
pubmed: 23095984
J Am Coll Cardiol. 2004 Apr 21;43(8):1423-9
pubmed: 15093878
BMC Health Serv Res. 2020 Jun 1;20(1):489
pubmed: 32487087
Crit Care Med. 2018 Jun;46(6):997-1000
pubmed: 29767636
Am Heart J. 2017 Sep;191:91-98
pubmed: 28888275
Eur J Intern Med. 2016 Mar;28:80-4
pubmed: 26751720
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Circulation. 2002 Oct 22;106(17):2194-9
pubmed: 12390947
BMJ. 2020 Mar 18;368:m441
pubmed: 32188600
J Am Coll Cardiol. 2012 Nov 13;60(20):2082-9
pubmed: 23083787
Sci Data. 2021 Feb 5;8(1):46
pubmed: 33547290
Circ Heart Fail. 2014 Nov;7(6):918-25
pubmed: 25281655
Eur J Heart Fail. 2013 Nov;15(11):1236-44
pubmed: 23787721
J Am Coll Cardiol. 2020 Aug 18;76(7):812-824
pubmed: 32792079
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015
Intensive Care Med. 2016 Apr;42(4):542-550
pubmed: 26891677
J Hypertens. 2020 Nov;38(11):2161-2168
pubmed: 32694334
JAMA. 2000 Mar 8;283(10):1295-302
pubmed: 10714728
Am Heart J. 2013 Feb;165(2):216-25
pubmed: 23351825
N Engl J Med. 2017 May 18;376(20):1956-1964
pubmed: 28402745
Circulation. 1999 Dec 7;100(23):2312-8
pubmed: 10587334
J Am Heart Assoc. 2019 Dec 3;8(23):e014240
pubmed: 31771438
Lancet. 2003 Sep 6;362(9386):772-6
pubmed: 13678870